Advanced Therapy of Inflammatory Bowel DiseaseThe main emphasis of this new edition is on diagnosis, therapy, and patient management, along with disease activity measures, IBD databases, and use of diagnostic tests in clinical decision making. Each chapter consists of recommendations from an expert in the field concerning a very specific IBD topic. Information is offered regarding the advantages and disadvantages of various drugs, combinations of drugs, and therapeutic or diagnostic procedures. Precise recommendations for instituting, modifying, and monitoring therapy as well as how complications can be anticipated, prevented and treated are also offered |
Contents
PATIENTDOCTOR INTERACTIONS | 1 |
PEDIATRIC PATIENT FAMILY DOCTOR INTERACTIONS | 5 |
ADHERENCE ISSUES IN MANAGEMENT OF INFLAMMATORY BOWEL DISEASE | 9 |
MANAGING INFLAMMATORY BOWEL DISEASE IN THE MANAGED CARE ERA | 13 |
MEDICALSURGICAL COLLABORATION IN PATIENT MANAGEMENT | 19 |
CONSULTATIONS AND THE PATIENT WITH INFLAMMATORY BOWEL DISEASE | 23 |
MEASURES OF DISEASE ACTIVITY | 25 |
COMPUTER DATABASE FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE | 29 |
CROHNS DISEASE THERAPEUTIC IMPLICATIONS OF DISEASE SUBTYPES | 333 |
THERAPEUTIC EXPECTATIONS OF MEDICAL MANAGEMENT OF CROHNS DISEASE | 337 |
SEQUENTIAL AND COMBINATION THERAPY FOR SMALL BOWEL DISEASE | 343 |
ORAL 5AMINOSALICYLIC ACID MEDICATIONS IN CROHNS DISEASE | 347 |
CLINICAL QUESTIONS IN CROHNS DISEASE NOT ANSWERED BY CONTROLLED TRIALS | 353 |
ANTIBIOTICS AS THERAPEUTIC AGENTS IN CROHNS DISEASE | 359 |
APPROPRIATE USE OF CORTICOSTEROIDS IN INFLAMMATORY BOWEL DISEASE | 363 |
TOPICALLY ACTIVE STEROID PREPARATIONS | 367 |
USEFUL BIOLOGIC MARKERS AS ACTIVITY INDICES | 35 |
IMAGING OF MUCOSAL INFLAMMATION | 39 |
CROHNS DISEASE COMPUTED TOMOGRAPHIC SCANNING IN CLINICAL DECISIONMAKING | 47 |
TRANSABDOMINAL BOWEL SONOGRAPHY IN CLINICAL DECISIONMAKING | 55 |
MODE OF ACTION OF ANTIINFLAMMATORY AGENTS | 63 |
MANAGEMENT OF DISTAL COLITIS | 69 |
TOPICALLY ACTIVE CORTICOSTEROIDS FOR COLITIS | 73 |
PSEUDOINTRACTABILITY OF INFLAMMATORY BOWEL DISEASE | 77 |
REFRACTORY DISTAL COLITIS | 81 |
COEXISTENCE OF INFLAMMATORY BOWEL DISEASE AND IRRITABLE BOWEL SYNDROME | 87 |
COEXISTENT IRRITABLE BOWEL SYNDROME AND INFLAMMATORY BOWEL DISEASE | 91 |
INFECTIOUS AGENTS AS AGGRAVATING FACTORS IN INFLAMMATORY BOWEL DISEASE | 95 |
USE OF NICOTINE AND TOBACCO IN COLITIS | 99 |
IMMUNOMODULATOR USE IN PATIENTS WITH DISTAL COLITIS | 103 |
MUCOSAL PROTECTIVE AND REPAIR AGENTS IN THE TREATMENT OF COLITIS | 107 |
THERAPEUTIC EXPECTATIONS MEDICAL MANAGEMENT OF ULCERATIVE COLITIS | 111 |
SEQUENTIAL AND COMBINATION THERAPY OF ULCERATIVE COLITIS | 115 |
ULCERATIVE COLITIS A DIVERSE DISEASE WITH DIVERSE QUESTIONS AND DIVERSE SOLUTIONS | 119 |
AMINOSALICYLATES THERAPY FOR ULCERATIVE COLITIS | 123 |
SYSTEMIC CORTICOSTEROIDS IN INFLAMMATORY BOWEL DISEASE | 127 |
STEROID UNRESPONSIVENESS IN INFLAMMATORY BOWEL DISEASE | 133 |
IMMUNOMODULATORS IN ULCERATIVE COLITIS | 139 |
MANAGEMENT OF SEVERE ULCERATIVE COLITIS | 143 |
USE OF ANTIBIOTICS AND OTHER ANTI INFECTIOUS AGENTS IN ULCERATIVE COLITIS | 149 |
MANAGEMENT OF ULCERATIVE COLITIS IN CHILDREN | 153 |
INDETERMINATE COLITIS | 157 |
DIETARY RECOMMENDATIONS FOR ACTIVE AND INACTIVE ULCERATIVE COLITIS | 161 |
NOVEL MANIPULATIONS OF INFLAMMATORY MEDIATOR PATHWAYS | 165 |
THERAPEUTIC EXPECTATIONS SURGICAL MANAGEMENT OF ULCERATIVE COLITIS | 171 |
INDICATIONS FOR COLECTOMY AND CHOICE OF PROCEDURES | 175 |
ROLE OF THE ENTEROSTOMAL THERAPY NURSE | 179 |
BROOKE ILEOSTOMY | 185 |
CONTINENT ILEOSTOMY KOCK POUCH | 191 |
ILEOANAL POUCH ANASTOMOSIS | 197 |
LONGTERM RESULTS WITH ILEOANAL POUCH | 203 |
ILEOANAL POUCH EVALUATION OF EXCESSIVE BOWEL MOVEMENTS | 209 |
ILEOANAL POUCH SURGERY IN CHILDHOOD | 215 |
CHRONIC POUCHITIS | 219 |
ENDOSCOPY IN EVALUATING ILEAL POUCHES | 225 |
ROLE OF THE PATHOLOGIST IN EVALUATING CHRONIC POUCHES | 229 |
SUPPORT FOR PATIENTS WHO UNDERGO OSTOMY AND POUCH SURGERY | 233 |
ILEORECTAL ANASTOMOSIS | 237 |
INDETERMINATE COLITIS SURGICAL APPROACHES | 241 |
GROWTH AND NUTRITIONAL PROBLEMS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE | 245 |
DYSPLASIA SURVEILLANCE PROGRAMS | 251 |
CANCER PREVENTION STRATEGIES IN INFLAMMATORY BOWEL DISEASE | 257 |
DYSPLASIA SURVEILLANCE IN CROHNS DISEASE | 263 |
EXTRAINTESTINAL MANIFESTATIONS | 267 |
CUTANEOUS MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE | 271 |
OCULAR MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE | 275 |
ARTHRITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE | 279 |
LESSONS FROM TREATMENT OF RHEUMATOID ARTHRITIS | 283 |
OSTEOPENIA AND OSTEOPOROSIS PREVENTION AND TREATMENT | 289 |
ISCHEMIC NECROSIS OF BONE | 293 |
SCLEROSING CHOLANGITIS | 299 |
STRICTURE MANAGEMENT IN PRIMARY SCLEROSING CHOLANGITIS | 303 |
LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS | 305 |
CHOLANGIOCARCINOMA IN THE INFLAMMATORY BOWEL DISEASE PATIENT | 311 |
GALLSTONE MANAGEMENT IN INFLAMMATORY BOWEL DISEASE | 317 |
UROLOGIC COMPLICATIONS | 321 |
HEMATOLOGIC PROBLEMS IN INFLAMMATORY BOWEL DISEASE | 325 |
PANCREATITIS IN INFLAMMATORY BOWEL DISEASE | 329 |
AZATHIOPRINE AND 6MERCAPTOPURINE USE IN CROHNS DISEASE | 373 |
AZATHIOPRINE METABOLISM IN INFLAMMATORY BOWEL DISEASE CORRELATION WITH EFFICACY AND TOXICITY | 377 |
METHOTREXATE IN INFLAMMATORY BOWEL DISEASE | 383 |
CYCLOSPORINE IN CROHNS DISEASE | 387 |
ANTICYTOKINE THERAPY IN CROHNS DISEASE | 389 |
PERIANAL FISTULA | 395 |
OPTIONS IN MANAGING ENTERAL FISTULAE IN INFLAMMATORY BOWEL DISEASE | 401 |
BOWEL REST AND PARENTERAL NUTRITION | 405 |
ENTERAL NUTRITION AND DIETARY MANAGEMENT | 409 |
CROHNS DISEASE IN CHILDREN AND ADOLESCENTS | 415 |
GASTRODUODENAL CROHNS DISEASE | 421 |
CROHNS JEJUNOILEITIS | 425 |
MEDICAL THERAPY OF CROHNS COLITIS | 429 |
FISTULIZING AND PERFORATING CROHNS DISEASE | 435 |
THERAPEUTIC EXPECTATIONS SURGICAL MANAGEMENT OF CROHNS DISEASE | 439 |
INDICATIONS AND PROCEDURES FOR SURGERY OF SMALL BOWEL CROHNS DISEASE | 443 |
PERIOPERATIVE NUTRITION SUPPORT | 449 |
LAPAROSCOPICALLY ASSISTED BOWEL RESECTION | 453 |
SURGERY FOR CROHNS DISEASE STRICTUREPLASTY | 457 |
GASTRODUODENAL CROHNS DISEASE SURGICAL MANAGEMENT | 461 |
MEASURES TO MINIMIZE POSTOPERATIVE RECURRENCES OF CROHNS DISEASE | 465 |
DIARRHEA FOLLOWING SMALL BOWEL RESECTION | 471 |
HYPEROXALURIA AND NEPHROLITHIASIS | 475 |
CLINICAL MANAGEMENT OF SHORTBOWEL SYNDROME | 479 |
INTESTINAL TRANSPLANTATION | 485 |
MANAGEMENT OF POSTOPERATIVE FISTULAE | 491 |
SURGERY FOR CROHNS COLITIS | 495 |
PERIANAL DISEASE | 501 |
ENDOSCOPIC MANAGEMENT OF SMALL BOWEL ANASTOMOTIC AND COLONIC STRICTURES IN CROHNS DISEASE | 509 |
RECTOVAGINAL FISTULAE | 515 |
FATE OF EXCLUDED BOWEL | 519 |
INFLAMMATORY BOWEL DISEASE GENETICS | 523 |
MANAGING PATIENTS CONCERNS | 527 |
LIFESTYLE ISSUES AND INFLAMMATORY BOWEL DISEASE | 531 |
INFLAMMATORY BOWEL DISEASE NURSE ADVOCATE | 535 |
CROHNS COLITIS FOUNDATION OF AMERICA INFORMATION AND SUPPORT SERVICES | 539 |
PEDIATRIC PATIENT AND FAMILY SUPPORT | 543 |
NUTRITIONAL CONSULTATION AND GUIDANCE | 547 |
QUESTIONS FREQUENTLY ASKED OF A SUPPORT SERVICE | 551 |
INSURANCE AND DISABILITY ADVOCACY ISSUES IN INFLAMMATORY BOWEL DISEASE | 555 |
SEXUAL ADJUSTMENTS AND BODY IMAGE | 561 |
ROLE OF CLERGY AND THE PATIENT WITH CHRONIC DISEASE | 565 |
APPRECIATION OF PSYCHOSOCIAL FACTORS | 569 |
PSYCHIATRIC COMPLICATIONS OF INFLAMMATORY BOWEL DISEASE | 573 |
PSYCHOLOGICAL PERSPECTIVES ON THE CARE OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE | 577 |
STRESS MANAGEMENT | 583 |
BEHAVIORAL PAIN MANAGEMENT | 587 |
PAIN MANAGEMENT | 593 |
FITNESS PROGRAMS | 599 |
ALTERNATIVE PATIENT CARE METHODS | 603 |
FERTILITY AND PREGNANCY IN INFLAMMATORY BOWEL DISEASE | 607 |
PREGNANCY AND INFLAMMATORY BOWEL DISEASE | 613 |
COLITIS IN THE ELDERLY | 619 |
NONSTEROIDAL ANTIINFLAMMATORY DRUGS ENTEROCOLONIC ULCERATION AND INFLAMMATORY BOWEL DISEASE | 625 |
COLLAGENOUS AND LYMPHOCYTIC COLITIS | 631 |
RADIATION ENTEROCOLITIS | 635 |
COLITIS AND ENTERITIS IN IMMUNOCOMPROMISED INDIVIDUALS | 639 |
LYMPHOMA IN INFLAMMATORY BOWEL DISEASE | 645 |
GASTROINTESTINAL COMPLICATIONS IN STEM CELL TRANSPLANTATION | 649 |
BEHCETS DISEASE | 655 |
THERAPY OF ULCERATIVE JEJUNOILEITIS | 659 |
Other editions - View all
Common terms and phrases
6-mercaptopurine abdominal abscess acid acute agents anal anastomosis antibiotics arthritis associated azathioprine biopsies bone budesonide cancer chapter cholangitis chronic clinical colectomy colon colonoscopy complications corticosteroids Crohn's colitis Crohn's disease cyclosporine develop diagnosis diarrhea diet disease activity distal dose drug dysplasia Editor's Note endoscopic enemas evaluation factors fecal fistulae Gastroenterol Gastroenterology gastrointestinal ileal ileoanal ileostomy ileum immunomodulator increased indeterminate colitis infection inflammation inflammatory bowel disease infliximab intestinal intravenous IPAA lesions liver long-term medical therapy mesalamine methotrexate metronidazole mg/d mucosa NSAIDs nutrition obstruction occur oral pain pancreatitis patients with Crohn's patients with IBD pediatric percent of patients perianal physician placebo postoperative pouch pouchitis prednisone rectal rectum recurrence refractory relapse Remicade remission require resection response risk side effects small bowel steroid stoma stool strictureplasty strictures studies sulfasalazine Supplemental Reading surgery surgical surveillance symptoms therapeutic tion toxicity transplantation treated treatment ulcerative colitis